Oral HPV Infection and Sexuality: A Cross-Sectional Study in Women by Ragin, Camille et al.
Int. J. Mol. Sci. 2011, 12, 3928-3940; doi:10.3390/ijms12063928 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Article 
Oral HPV Infection and Sexuality: A Cross-Sectional Study  
in Women  
Camille Ragin 
1,*, Robert Edwards 
2, Margaret Larkins-Pettigrew 
2, Emanuela Taioli 
3,  
Stacy Eckstein 
4, Natalie Thurman 
4, Jessica Bloome 
5 and Nina Markovic 
4 
1  Cancer Prevention and Control Program, Fox Chase Cancer Center, PA 19111, USA 
2  Division of Gynecologic Oncology, Magee Women’s Hospital, University of Pittsburgh, Pittsburgh, 
PA 15260, USA; E-Mails: edwarp@mail.magee.edu (R.E.); drpettigrew@aol.com (M.L.-P.) 
3  Institute of Translational Epidemiology, Mt. Sinai Medical Center, NY 10029, USA;  
E-Mail: taiolema@gmail.com 
4  Department of Epidemiology, University of Pittsburgh, Graduate School of Public Health and the 
University of Pittsburgh Cancer Institute, PA 15260, USA; E-Mails: ste11@pitt.edu (S.E.); 
thurman_natalie@yahoo.com (N.T.), ninam@pitt.edu (N.M.) 
5  Department of Epidemiology, State University of New York, Downstate Medical Center, 
NY 11203, USA; E-Mail: jessica.bloome@gmail.com 
*  Author to whom correspondence should be addressed; E-Mail: camille.ragin@fccc.edu;  
Tel.: +1-215-728-1148; Fax: +1-215-214-1622. 
Received: 1 March 2011; in revised form: 12 April 2011 / Accepted: 3 June 2011 /  
Published: 10 June 2011 
 
Abstract: Human Papillomavirus (HPV) is the main risk factor for cervical cancers and is 
associated with close to 36% of oropharyngeal cancers. There is increasing evidence that 
oral HPV transmission is related to sexual behavior but to our knowledge studies that 
involve women who have sex with women have not been performed. We examined the 
prevalence of oral HPV according to sexual behavior among a population-based sample of 
118 women and have made some inferences of possible predictors of oral HPV infection. 
Women were categorized as heterosexual (history of vaginal sex and/or oral sex with males 
only, n = 75), bisexual (history of vaginal sex and oral sex with females, n = 32) and other 
(no history of vaginal sex but oral sex with females [homosexuals], virgins and women 
with incomplete sexual exposure data, n = 11) The prevalence of oral HPV infection was 
12/118  (10.2%)  for  the  overall  study  population  and  was  not  significantly  different 
between heterosexual and bisexual women (10.7% (8/75) vs. 12.5% (4/32), p = 0.784). 
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There was no oral HPV detected among homosexual women, virgins or among women 
where sexual exposure was unknown. Never smokers were more likely to be oral HPV+ 
compared to former smokers (Adjusted Odds Ratio (Adj OR) = 0.1, 95% CI, 0.0–1.1) and 
there was no difference in risk between never smokers and current smokers (Adj OR = 0.7, 
95% CI, 0.1–4.6). Twenty-five percent (3/12) of oral HPV+ women had a history of HPV 
and/or genital warts compared to 9% (10/106) of oral HPV-women (p = 0.104). For the 
women  with  a  history  of  vaginal  sex  (n  =  110),  oral  HPV  status  was  statistically 
significantly different according to oral sex exposure (p = 0.039). A higher proportion of 
oral HPV-positive women reported that they had no history of oral sex exposure compared 
to oral HPV-negative women (4/12, 33% vs. 7/98, 8%). The prevalence of cervical HPV 
infection  did  not  vary  between  heterosexuals  and  bisexuals  (35.7%  (25/70)  vs.  35.5% 
(11/31),  p-value  0.411)  and  for  all  other  women  the  cervical  HPV  prevalence  was 
significantly lower (11.1%, 1/9). Our study suggests that smoking and sexual behavior 
involving  males  rather  than  female  partners  may  be  possible  predictors  of  oral  HPV 
infection  in  women.  Further  studies  with  larger  sample  size  are  needed  to  confirm  
these findings.  
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1. Introduction 
Human Papilloma Virus (HPV) is the main risk factor for cervical cancers and is associated with 
about  25%  of  head  and  neck  cancers,  including  close  to  36%  of  oropharyngeal  cancers  [1,2].  In  
case-control  studies  of  oral  HPV,  prevalence  among  controls  ranged  from  5.0%  to  9.2%  [3,4]. 
Population-based cross-sectional studies have shown widely varying prevalence of HPV in the normal 
oral mucosa, from 0.6% to 81% [5–16]. One review found a prevalence of oral HPV infection among 
healthy people to be 13.5% [12], while a study in Finland with 2 years of follow-up found oral HPV 
prevalence rates fluctuating between 15–27% [13]. 
Despite evidence of HPV as an etiologic risk factor for head and neck cancer, most notably HPV 
type 16  [17], there are  few population-based studies  on mechanisms  of HPV transmission.  Initial 
studies have shown smoking, age, and HIV positive serostatus as risk factors [10,18]. A recent review 
by  Termine  et  al.  evaluated  the  prevalence  of  oral  HPV  infection  in  women  with  cervical  HPV 
infection and performed a meta analysis of the current literature [19]. The pooled prevalence of oral 
HPV  infection  was  18.1%  (95%  CI:  10.3–25.9)  and  the  only  significant  predictor  of  oral  HPV 
infection was a younger age at first sexual intercourse and no association was found between oral HPV 
infection and oral/genital sex. However, the gender of the sexual partner was not considered in these 
analyses and it is not yet clear whether the relationship between sexual behavior and risk of oral HPV 
infection  differs  according  to  the  gender  of  the  sexual  partner.  Furthermore,  there  is  increasing 
evidence  from  case-control  studies  that  oral  HPV  status  may  be  related  to  sexual  behavior,  and 
particularly  oral  sexual  behavior.  Case-control  studies  of  head  and  neck  cancer  have  shown 
associations with number of sexual partners, history of oral-genital contact, history of genital warts, Int. J. Mol. Sci. 2011, 12                       
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and age at first intercourse [4,18]. Males with HPV-positive tumors were also more likely to report a 
partner  with  history  of  abnormal  Pap  smear  or  cervical  dysplasia  [18].  This  suggests  that  sexual 
behavior risk factors are a proxy for exposure to high risk HPV types. A recent study of risk factors for 
oral HPV indicated not only number of vaginal and oral sex partners, but also number of kissing 
partners were associated with oral HPV status [5]. To our knowledge, there are no studies that have 
evaluated the risk of oral HPV infection based on sexual behaviors by comparing the gender of the sex 
partners. More data are needed to confirm the main route of oral HPV transmission. 
Among women who have sex with women, previous studies have shown cervical HPV prevalence 
of  13%  and  30%,  including  cases  among  women  with  a  history  of  exclusively  female  sexual  
partners [20–22]. This indicates sexual transmission of HPV may occur between women. In this study 
we have examined the prevalence of oral HPV and we have evaluated the sexual behaviors in women 
in order to identify potential risk factors associated with oral HPV infection.  
2. Methods 
2.1. Study Population 
This cross-sectional study involves participants who were enrolled in the Epidemiologic Study of 
HEalth Risk (ESTHER) project (a study of cardiovascular disease focused in comparisons between 
heterosexual  and  homosexual  women).  The  ESTHER  project’s  participants  were  recruited  from 
participants attending women-focused events, news items and advertisements in women-focused news 
sources  throughout  the  city  of  Pittsburgh,  Pennsylvania.  Following  approval  by  the  University  of 
Pittsburgh Biomedical Institutional Review Board (IRB), each ESTHER project participant (N = 1043) 
was  contacted  by  the  study  coordinator  (by  mail  and  a  follow  up  telephone  call)  and  invited  to 
participate in this pilot study and if they agree to do so they were consented prior to initiation of the 
study. All women were called at least once for recruitment into this study and 88 agreed to participate 
(self-identified  heterosexual  women  =  52;  self-identified  homosexual  women  =  36).  All  study 
participants were required to be seen at one clinic visit by trained research staff in the Magee Womens 
Hospital  Clinical  &  Translational  Research  Center  (CTRC).  In  addition  the  study  population  was 
enriched  with  30  African-American  participants  who  were  also  enrolled  during  their  routine 
gynecologic clinic visit at the Magee Womens Hospital.  
2.2. Sample and Data Collection 
During  the  clinic  visit,  an  oral  brushing,  mouthwash  and  a  cervical  brushing  was  collected  to 
determine HPV status and the type of HPV present. The oral brush of the tonsils was collected first 
using 10 strokes (5 on each side) with a sterile nylon bristle cytology brush. This was followed by the 
mouthwash collection which required gargling 1–2 min while tilting the head back slightly toward the 
back of the throat. The goal was to gather exfoliated cells from the tonsil area. The results from  
each  of  these  sampling  techniques  were  combined  to  provide  the  oral  HPV  status.  For  the  30  
African-American women, only a mouthwash sample was collected.  
Women who had a Pap smear performed within the previous 12 months prior to the study visit and 
had the results available were given the option of providing these results at the time of their study visit. Int. J. Mol. Sci. 2011, 12                       
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Other participants had a Pap smear specimen collected by a study nurse, during their study visit. These 
Pap smears were read by qualified personnel at Magee Women’s Hospital, Department of Cytology 
and confirmed by a pathologist. The results of these Pap smears were made available to each study 
participant at no cost. Women with abnormal Pap test results were referred for follow up with their 
primary  care  provider.  If  the  participant  did  not  have  their  own  primary  care  provider,  one  was 
recommended  to  them.  History  of  abnormal  cervical  cytology  (ASCUS,  CIN  or  cancer)  was 
determined  by  combining  the  history  collected  from  questionnaire  data  with  Pap  smear  results 
generated at the time of study enrollment and/or 12 months prior to the time of study enrollment. All 
participants  were  asked  in  the  questionnaire  whether  they  had  a  history  of  abnormal  Pap  smears  
(i.e., prior to their enrollment in this study). For the participants who answered no to this question, if 
the Pap smear collected during this study were abnormal (ASCUS, CIN or cancer) they were also 
classified as having a history of abnormal Pap smears.  
Self-reported  sexual  orientation,  age,  smoking  status,  history  of  previous  abnormal  cytology 
diagnoses, history of cervical cancer diagnosis, and sexual behavior (oral and vaginal sexual practices, 
previous diagnosis of HPV/genital warts, and other sexually transmitted diseases) were obtained for 
each  participant.  In  this  analysis  self-reported  sexual  orientation  was  not  used  because  it  did  not 
correlate with reported sexual behavior patterns. Instead sexual orientation was redefined based on the 
combination of vaginal and oral sex exposure data and was categorized as heterosexual, bisexual or 
other  (homosexuals,  virgins  and  women  with  incomplete  sexual  exposure  data).  Women  with 
heterosexual  exposure  were  defined  as  having  had  vaginal  sex  and/or  oral  sex  with  males  only. 
Women  with  bisexual  exposure  had  vaginal  sex  and  had  oral  sex  with  females  and  those  with 
homosexual exposure never had vaginal sex and only had oral sex with females. 
2.3. Laboratory Testing 
DNA was extracted from all cervical and oral samples using the Puregene DNA purification kit 
(Qiagen, Germantown, MD, USA) and HPV genotyping was performed using the Linear Array HPV 
Genotyping kit (Roche Diagnostics). The details of HPV genotyping and classification of high-risk 
HPV types  has  been previously  described  [23]. HPV status was  recorded as  positive or negative. 
HPV52 cannot be specifically detected using the  Linear Array HPV Genotyping protocol. The kit 
contains a cross-reactive probe that detects HPV 33, 35, 52 and 58 combined. Samples that are positive 
for HPV 33, 35, and/or 58 individually, as well as the cross-reactive probe have an uncertain HPV 52 
status. For our study these samples were interpreted as probably positive for HPV 52.  
Classification of HPV-risk was based on the epidemiological classification of HPV types associated 
with cervical cancer [24]. HPV types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82 are 
considered high-risk HPV types; HPV types: 26, 53, 66 are considered probable high-risk HPV types 
and HPV types: 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, CP6108 are considered low-risk HPV types. 
For this study, the probable high-risk HPV types and high-risk HPV types were grouped together. All 
other HPV types that have not been classified as high- or low-risk were classified as undetermined risk. Int. J. Mol. Sci. 2011, 12                       
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2.4. Statistical Analysis  
Statistical analysis was performed using STATA 10 (StataCorp LP, College Station, TX). Fisher’s 
exact  tests  were  performed  to  test  for  group  differences  between  oral  HPV-positive  and  negative 
groups, with oral HPV status defined by a positive result for either mouthwash or oral brush samples. 
A  p-value  <  0.05  was  considered  statistically  significant  and  p  >  0.05  and  <0.1  was  considered 
marginally  statistically  significant.  Exact  logistic  regression  analyses  were  performed  in  order  to 
identify the predictors of oral HPV infection [25]. The conditional maximum likelihood estimates 
(CMLEs) are reported and when the parameters for the CMLEs are infinite, median unbiased estimates 
(MUEs) were reported.  
3. Results 
3.1. Characteristics of the Study Population and Factors Related to Oral HPV Infection  
There were 118 women included in this study population. Seventy-five (63.6%) were heterosexual 
(had vaginal sex and/or oral sex with males only), 32 (27.1%) were bisexual (had vaginal sex and had 
oral sex with females) and 11 (9.3%) were categorized as other (homosexual exposure or unknown 
exposure). The oral HPV prevalence for the entire study population was 10.2% (12/118) and was not 
different between heterosexuals and bisexuals (10.7% (8/75) vs. 12.5% (4/32), p = 0.784). None of the 
women that were categorized as “other” were positive of oral HPV infection. Table 1 summarizes the 
study participants’ demographic and key behavioral characteristics according to oral HPV status. Ages 
ranged  from  24–78  years,  with  a  mean  age  of  51.8  years.  There  were  no  statistically  significant 
differences for oral HPV status according to race or age. There was a marginal difference in smoking 
status based on oral HPV infection (p = 0.068). A larger proportion of the oral HPV-positive women 
were  never  smokers  compared  to  the  oral  HPV-negative  women  (75%  (9/12)  vs.  54%  (56/104)). 
Among the women that were ever smokers, the distribution of former versus current smokers was 
different according to oral HPV status. The majority of the oral HPV-positive women were current 
smokers rather than former smokers (2/12, 17% vs. 1/12, 8%) while the opposite was observed for the 
oral HPV-negative women. After adjusting for age, age at first vaginal sex and oral sex exposure, and 
using never smokers as the reference  group, the odds  of oral  HPV-positivity for current  smokers 
compared to never smokers was not statistically significantly different (Adj OR: 0.7, 95% confidence 
interval  [CI]:  0.1–4.6) while  for former smokers,  the odds  of oral  HPV-positivity was  marginally 
statistically significantly lower (Adj OR: 0.1, 95% CI: 0.0–1.1). 
Table 1. Population characteristics and lifestyle factors according to oral HPV status. 
  
Oral HPV-Negative 
N = 106  
N (%)  
Oral HPV-Positive 
N = 12 
N (%) 
p-Value † 
Race       
 White  63 (59.4)  8 (66.7)  0.612 
 Black  37 (34.9)  3 (25.0)   
 Other  5 (4.7)  1 (8.3)   Int. J. Mol. Sci. 2011, 12                       
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Table 1. Cont. 
Unknown  1 (0.9)  0 (0.0)   
Age       
 <53 years  54 (50.9)  7 (58.3)  0.764 
 53+ years  52 (49.1)  5 (41.7)   
Smoking status §        
 Never smoker  56 (53.9)  9 (75.0)  0.068 
 Former smoker  39 (37.5)  1 (8.3)   
 Current smoker  9 (8.7)  2 (16.7)   
       
Ever engaged in vaginal sex (n = 116) §        
 Yes  98 (94.2)  12 (100.0)  1.000 
 No  6 (5.8)  0 (0.0)   
Lifetime number of vaginal sex partners (n = 108) §        
 1  20 (20.6)  1 (9.0)  0.438 
 2-5  51 (52.6)  5 (45.5)   
 6+  26 (26.8)  5 (45.5)   
Lifetime number of oral sex partners (male and/or female) (n = 101) *     
 1  21 (22.6)  1 (12.5)  0.682 
 2–5  72 (77.4)  7 (87.5)   
Age at first oral sex exposure (Male and/or Female) (n = 96) **     
 ≤21 years  47 (52.8)  3 (42.9)  0.707 
 >21 years  42 (47.2)  4 (57.1)   
Oral sex exposure among non-virgins (n = 106) ¥        
 oral sex male exposure θ  78 (83.0)  7 (58.3)  0.039 
 oral sex female only exposure  9 (9.6)  1 (8.3)   
 No oral sex exposure  7 (7.5)  4 (33.3)   
† Fisher’s exact test; * one woman was excluded due to missing information; §  two women were 
excluded due to missing information; ¥  four women were excluded that reported no to history of 
oral sex with males but history of oral sex with females was unknown; ** five women excluded sue 
to missing data; θ includes women with oral sex exposure to males and females, oral sex exposure 
to males only or oral sex exposure to females was unknown  
Although there was no statistically significant difference in oral HPV infection based on vaginal sex 
exposure (12/12, 100% vs. 98/104, 94%), the prevalence of oral HPV appears to increase with the 
number of vaginal sex partners (Table 1). Among the women with a history of vaginal sex (n = 110), 
oral HPV status was statistically significantly different according to oral sex exposure (p = 0.039). A 
higher proportion of oral HPV-positive women reported that they had no history of oral sex exposure 
compared to oral HPV-negative women (4/12, 33% vs. 7/98, 8%). After adjusting for age, age at first 
vaginal sex and smoking, women who reported a history of vaginal sex but no oral sex exposure were 
more than six times likely to be oral HPV-positive compared to women who reported a history of 
vaginal sex and oral sex with males (Adj OR: 6.6, 95% CI: 1.0–43.3). There were no differences in 
oral HPV infection according to the total number of oral sex partners (data not shown). A higher 
proportion of women that were oral HPV-positive were over the age of 21 years old when they had Int. J. Mol. Sci. 2011, 12                       
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their first oral sex exposure compared to the oral HPV-negative women (4/7, 57% vs. 42/89, 47%) but 
this difference was not statistically significant.  
Table 2 describes the relationship between oral HPV infection and cervical HPV infection, history 
of abnormal cervical cytology and history of sexually transmitted diseases including HPV and genital 
warts. No differences were observed according to oral HPV status except a marginal difference in the 
proportion of women with a history of HPV infection or genital warts was observed. Twenty-five 
percent (3/12) oral HPV-positive women had a history of HPV and/or genital warts compared to 9% 
(10/106) of oral HPV-negative women (p = 0.104). 
Table 2. Oral HPV status and other clinical factors. 
  
Oral HPV-Negative 
N = 106  
N (%)  
Oral HPV-Positive 
N = 12 
N (%) 
p-Value † 
Cervical HPV       
 Not Present  67 (63.2)  6 (50.0)  0.525 
 Present  32 (30.2)  5 (41.7)   
 Not done  7 (6.6)  1 (8.3)   
History of abnormal cervical cytology (109) #       
 No  67 (67.7)  8 (80.0)  0.721 
 Yes  32 (32.3)  2 (20.0)   
History of STD Diagnosis §        
 No  73(68.9)  9 (75.0)  0.504 
 Yes  29 (27.4)  2 (16.7)   
 Not sure/Unknown  4 (3.8)  1 (8.3)   
History of HPV/genital warts       
 No  93 (87.7)  8 (66.7)  0.104 
 Yes  10 (9.4)  3 (25.0)   
 Not sure/Unknown  3 (2.8)  1 (8.3)   
# 9 women were excluded were missing questionnaire data history of abnormal cervical cytology 
(i.e.,  greater  than  12  months  prior  to  study  enrollment);  §   History  of  being  diagnosed  with  a 
sexually  transmitted  disease,  such  as  herpes,  chlamydia,  gonorrhea,  syphilis,  trichomonas  and  
HIV infection. 
For  all  of  the  women  combined,  irrespective  of  sexual  exposure,  the  prevalence  of  oral  HPV 
infection appears to vary inversely with age when compared to cervical HPV infection (Figure 1A). As 
expected, cervical HPV infection was highest for women 24–47 years and appears to decrease as age 
increases. In contrast oral HPV infection was lowest in women 24–47 years and appears to increase as 
age increases. A similar trend was observed for heterosexual women (Figure 1C) but for bisexual 
women,  cervical  HPV  infection  was  lower  for  younger  women  and  highest  for  women  ages  
48–57 years (Figure 1B). Oral HPV infection in bisexual women also was highest for women ages  
48–57 years. All other women (homosexuals, virgins and women with incomplete sexual exposure 
data)  were not  oral  HPV-positive, and  while cervical  HPV infection was  detected in  the  younger 
women ages 24–47 (data not shown).  Int. J. Mol. Sci. 2011, 12                       
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Figure 1. Prevalence of oral and cervical HPV infection according age and type of sexual 
exposure (A) all women (B) Bisexual (C) Hetersexual. 
 
3.2. Cervical HPV and Oral HPV Infections  
Among the 12 women found to be infected with oral HPV, five women (42%) had at least one 
known or probable high risk HPV type, 5 (42%) women had HPV types of unknown risk and 2 (16%) 
women had low risk HPV infections. Three of the twelve women (25%) with oral HPV infection had 
more than one HPV types present. One woman was infected with high-risk HPV types 16 and 33, the 
other with  high-risk HPV types  35 and 52 and the third was  infected  with  high-risk HPV66 and  
low-risk HPV70.  
In contrast to oral HPV infections, 33.6% (37/110) of the women had detectable cervical HPV 
infections and among these, more than half of them (20/37, 54%) were infected with at least one 
known or probable high-risk HPV type and (18/37, 49%) were infected with multiple HPV types. The 
prevalence of cervical HPV infection did not vary between heterosexuals and bisexuals (35.7% (25/70) 
vs.  35.5%  (11/31),  p-value  0.411)  and  for  all  other  women  the  cervical  HPV  prevalence  was 
significantly lower (11.1%, 1/9). The frequency of high risk types detected in the cervical mucosa 
ranked from highest to lowest were 52, 33, 56, 35, 59, 68, 16, 18, 39, 45, 51 and 58. The mean age of 
women with cervical HPV infection was lower (49 years old; range = 24–67 years) than the mean age 
of women with oral HPV infection (53  years old; range = 37–66  years.) but was not statistically 
significantly different (p = 0.257). 
Table 3 summarizes the HPV types detected in both the cervical and oral sites for the women that 
were oral HPV-positive. There were no similarities in the HPV types detected in the oral and cervical 
mucosa except that one woman who had HPV52 infections in both sites (Table 3). Int. J. Mol. Sci. 2011, 12                       
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Table 3. Cervical HPV infection in oral HPV-positive women 
HPV Type 
(oral) 
HPV Type 
(cervix) 
35, (52)  Negative 
16, 33  -- 
52  40, 52, 84 
54  Negative 
61  83 
66,70  84, CP6108 
82  Negative 
83  61, 62 
83  Negative 
84  61 
84  Negative 
84  Negative 
(52) = cannot rule out the presence of HPV52; -- Not done. 
4. Discussion 
HPV  is  found  to  be  associated  with  cancer  in  the  oropharynx  [26],  therefore  the  relevance  of 
defining  risk behaviors  related to  oral  HPV infection in  healthy populations  may help  to  identify 
persons with an increased risk of oral HPV infection. This information would be beneficial and could 
potentially lead to the implementation of targeted public health interventions that would reduce the 
likelihood of oral HPV infection in the healthy population. Although HPV-related oral tumors occur in 
both males and females, only a few studies have investigated the prevalence of oral HPV infection in 
women in order to identify key sexual behavior factors that could be related to oral HPV infection in 
this  population.  The  prevalence  of  oral  HPV  infection  in  our  study  population  was  low  and  is 
consistent with what has been previously reported in the normal oral mucosa [12,19,27,28]. Although 
participants  provided self-defined sexual  orientation data, this  classification did  not  correlate  with 
sexual behavior. Women who described themselves as homosexuals also reported a history of sexual 
involvement with males. Therefore to better categorize the participants according to sexual behavior, 
we redefined sexual orientation based on the combination of both vaginal and oral sex exposure.  
In our study population, there was no significant difference in the prevalence of HPV infection 
between heterosexual and bisexual women (10.7% (8/75) vs. 12.5% (4/32)). In contrast, there was no 
oral HPV detected among homosexual women, virgins or among women where sexual exposure was 
unknown. This suggests that oral HPV infection may be more likely associated with sexual exposure to 
male partners rather than females and further studies are needed to confirm this finding. When oral sex 
behavior was compared among women who had vaginal sex exposure, there seemed to be an increased 
prevalence  of  oral  HPV  infection  for  the  women  that  had  vaginal  sex  exposure  but  no  oral  sex 
exposure. This also suggests that that vaginal sex exposure may be a stronger predictor for oral HPV 
infection.  This  is  supported  by  results  from  a  recent  meta-analysis  by  Termine,  et  al.  The  study 
involved 100 women and reported that the only significant predictor of oral HPV infection was a 
younger age at first sexual intercourse and no association was found for other types of sexual behavior 
such as oral and genital sex and the presence of HPV-related cervical lesions [19]. Considering the Int. J. Mol. Sci. 2011, 12                       
 
3937 
small number of non-virgin women that reported no oral sex exposure in our study population (n = 11), 
these findings should be interpreted with caution and will need to be confirmed in future studies with a 
much larger sample size.  
Previous studies have found an association between oral HPV status and number of vaginal sex 
partners, oral sex partners, and kissing partners [5,10]. In our study, we did not evaluate the number of 
kissing  partners  but  we  also  observed  an  increasing  trend  of  positive  oral  HPV  infections  as  the 
number of lifetime vaginal sex partners increased. In addition, a history of genital HPV infection or 
warts in our study seems to contribute to positive oral HPV infections. The lifetime number of sexual 
partners may not be the best measure of recent sexual activity since it is not yet clear from these data 
the relationship between timing of oral sex exposure (recent rather than past) and oral HPV status. 
Therefore age at first vaginal sex exposure as well as age at first oral sex may be more informative. We 
evaluated the relationship between age at first oral sex exposure and oral HPV status and observed that 
a slightly higher proportion of women who were older than 21 years at the time of their first oral sex 
exposure were oral HPV-positive but this was not statistically significantly different from the oral 
HPV-negative women possibly due to our small sample size. To address the limitations in this current 
study design, a longitudinal study that includes the evaluation of age at first sexual exposure, recent 
sexual  exposure,  HPV  infection  and  persistence  might  provide  new  insights  into  the  risk  of  oral  
HPV infection.  
We observe a statistically significant difference in smoking status among those women who were 
oral HPV-positive compared to those who were oral HPV-negative. From our results never smokers as 
well as current smokers may be more likely to be oral HPV-positive. This observation was marginally 
statistically  significant  even  after  adjusting  for  age  and  sexual  behavior  factors.  Vacarella,  et  al. 
reported that the current smoking was associated with the prevalence of cervical HPV infection while 
there was no association observed for former smokers [29] and similar findings have been reported by 
others [30,31]. These studies of have shown the association of cervical HPV prevalence with cigarette 
smoking while studies of HPV in head and neck cancer have reported HPV-positive tumors tend to be 
located in the oropharynx in nonsmokers yet HPV-positive head and neck tumors are also detected in 
smokers as well. Therefore further investigation and interpretation of these findings in larger studies 
are warranted.  
A recent study of the natural history of oral HPV reported that persons were significantly more 
likely to be infected with HPV when their spouse had a persistent infections lasting for the 2 year 
duration of the study [13]. In our study we attempted to collect information about the history of HPV 
infection  among  the  sexual  partner(s)  of  the  participants  in  this  study  but  this  information  was 
incomplete  and  could  not  be  evaluated  due  to  this  limitation  in  our  study  design.  We  have  also 
considered that the low response rate in this study is also another limitation. Of the 1043 women that 
were invited to participate, only 88 agreed, suggesting that the population may not be representative of 
the  original  pool  of  potential  participants.  In  an  attempt  to  improve  our  small  sample  size,  
30 additional women were recruited during routine gynecologic clinic visits at the same institution. 
While the small sample size limited our analyses, with this consideration, exact conditional logistic 
regression analyses were appropriately used [25] to calculate odds ratios for possible predictors of oral 
HPV infection. For small samples, exact regression analysis produces more accurate inference because 
the calculation does not depend on asymptotic results. Furthermore, exact logistic regression is better Int. J. Mol. Sci. 2011, 12                       
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able to handle one-way causation, e.g., scenarios where all of the participants are observed to have a 
positive outcome. Since the confidence intervals for exact logistic regression models are calculated 
from the exact conditional distributions and are asymmetrical about the estimate, they tend to be wider 
than the normal-based confidence intervals derived from logistic regression models.  
5. Conclusions  
Overall our findings suggest that sexual behavior and smoking status may be contributing factors 
that are related to oral HPV infection in women. It is also possible that in women, sexual exposure to 
male partners may be more predictive of oral HPV infection rather than sexual exposure to female 
partners  but  further  studies  with  larger  sample  size  and  with  a  study  design  that  addresses  the 
limitations and lessons learned from this current study are needed to confirm these findings.  
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